Fundz

Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer - Technology Today - EIN Presswire

PRIVATEAug 21, 2023

Position

Chief Technology Officer

Company

Adverum Biotechnologies

Andrew Ramelmeier
aramelmeier@adverum.com
Redwood CityBiotechnologyHealth CareMedicalTherapeutics

Description

/ EIN News / -- REDWOOD CITY, Calif., Aug. 21, 2023 -- Adverum Biotechnologies, Inc. , a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that R

Quick answer

Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer - Technology Today - EIN Presswire (August 21, 2023). Adverum Biotechnologies is based in Redwood City, California, United States.

Who is the new Chief Technology Officer at Adverum Biotechnologies?
Adverum Biotechnologies named Andrew Ramelmeier Chief Technology Officer, announced August 21, 2023.
What did Adverum Biotechnologies announce on August 21, 2023?
/ EIN News / -- REDWOOD CITY, Calif., Aug. 21, 2023 -- Adverum Biotechnologies, Inc. , a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that R
What does Adverum Biotechnologies do?
At Adverum, we are driven to establish gene therapy as a new standard of care for debilitating ocular diseases.
Where is Adverum Biotechnologies based?
Adverum Biotechnologies is based in Redwood City, California, United States.
Which similar companies made leadership changes around the same time?
Arcutis (August 18, 2023), Imugene (September 1, 2023), Hansa Biopharma (September 1, 2023) and Apex Labs (August 10, 2023) also announced leadership changes within 45 days of Adverum Biotechnologies.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Adverum Biotechnologies, and when

A new leader at Adverum Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Adverum Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adverum Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adverum Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adverum Biotechnologies

Location

Redwood City, California, United States

About

At Adverum, we are driven to establish gene therapy as a new standard of care for debilitating ocular diseases. Adverum aspires to transform the standard of care, preserve long-term vision, and create a profound societal impact around the globe, by advancing gene therapies for highly prevalent ocular diseases. Leveraging the research capabilities of our IVT platform, we design durable medicines that can be administered in the physician’s office, eliminate the need for frequent retinal injections, in an effort to greatly improve accessibility to treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adverum Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Andrew
Likely contact at this company
••••••••@••••••••

See Andrew's verified email →

Yoon
Likely contact at this company
••••••••@••••••••

See Yoon's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Adverum Biotechnologies's next move

Learn about Strategic plan

Adverum Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.